e-learning
resources
Berlin 2008
Monday, 06.10.2008
Diagnostic aspects in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic significance of ADAM8 and M2-PK in non-small cell lung cancer
Y. Zhou, X. Zeng, Y. Wu, D. Xue, X. Tan (Guangzhou, China)
Source:
Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Session:
Diagnostic aspects in thoracic oncology
Session type:
Thematic Poster Session
Number:
2627
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Zhou, X. Zeng, Y. Wu, D. Xue, X. Tan (Guangzhou, China). Diagnostic significance of ADAM8 and M2-PK in non-small cell lung cancer. Eur Respir J 2008; 32: Suppl. 52, 2627
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Prognostic significance of Nestin in resected non-small cell lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
The prognostic significance of sVEGF levels in patients(pts) with Non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 363s
Year: 2003
Prognostic significance of S-100 immmunostaining in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2004 - Prognostic factors
Year: 2004
Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Clinical significance and functional roles of FoxM1 in non-small cell lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer
Source: Annual Congress 2008 - New imaging techniques in chest imaging
Year: 2008
Ki-67 in non-small cell lung cancer
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
Prognostic value of p21 protein expression in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 674s
Year: 2004
Survivin expression in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Prognostic value of comorbidity in operated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 763s
Year: 2006
Prognostic factors in non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Diagnostic value of EBUS in staging of nonsmall cell lung carcinoma
Source: Annual Congress 2008 - Endoscopic needle techniques
Year: 2008
The value of CD44 and MMP-2 expression in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004
Soluble non-invasive markers in non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005
Prognostic value of Her2/
neu
in stage IIIA non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006
Expression and significance of VE-cadherin and E-cadherin in non-small cell lung cancer
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Features of N-staging in left-sided non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006
Apelin expression is a prognostic factor in non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept